• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者基线全身 MRI 的观察者间一致性。

Inter-observer agreement of baseline whole body MRI in multiple myeloma.

机构信息

The Institute of Cancer Research, London, UK.

The Royal Marsden Hospital, London, UK.

出版信息

Cancer Imaging. 2020 Jul 14;20(1):48. doi: 10.1186/s40644-020-00328-9.

DOI:10.1186/s40644-020-00328-9
PMID:32665028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7362571/
Abstract

BACKGROUND

Whole body magnetic resonance imaging (MRI) is now incorporated into international guidance for imaging patients with multiple myeloma. The aim of this study was to investigate inter-observer agreement of triple reported baseline whole-body MRI in myeloma and highlight potential pitfalls.

METHODS

Fifty-seven patients with symptomatic myeloma at first presentation or relapse and planned for autologous stem cell transplant were included. All patients completed baseline whole body MRI within 2 weeks prior to starting treatment. Each scan was reported independently by 3 radiologists using a defined scoring system. Differences in observer scores were compared using analysis of variance (ANOVA) and inter-observer agreement assessed using intra class correlation coefficient (ICC).

RESULTS

There was no significant difference in mean observer scores for whole skeleton and ICC demonstrated excellent inter-observer agreement at 0.91. ICC varied between skeletal regions with spine, pelvis and ribs showing good inter-observer agreement, whereas skull and long bones were moderate. Scans with variation in observer scores were re-examined and cause of discrepancies identified. This information was used to describe potential anatomical pitfalls in reporting .

CONCLUSION

Whole-body MRI has excellent inter-observer agreement in reporting symptomatic myeloma at baseline. Inter-observer agreement varied between skeletal regions highlighting specific areas of difficulty.

摘要

背景

全身磁共振成像(MRI)现已纳入多发性骨髓瘤患者影像学检查的国际指南。本研究旨在探讨多发性骨髓瘤患者基线全身 MRI 三重报告的观察者间一致性,并强调潜在的误区。

方法

57 例初诊或复发的有症状多发性骨髓瘤患者计划接受自体干细胞移植。所有患者均在治疗前 2 周内完成基线全身 MRI 检查。每个扫描均由 3 名放射科医生独立使用定义的评分系统进行报告。使用方差分析(ANOVA)比较观察者评分的差异,并使用组内相关系数(ICC)评估观察者间的一致性。

结果

整体骨骼的平均观察者评分无显著差异,ICC 显示观察者间具有极好的一致性,为 0.91。ICC 在骨骼区域之间存在差异,脊柱、骨盆和肋骨具有良好的观察者间一致性,而颅骨和长骨则为中度。对观察者评分存在差异的扫描进行重新检查,并确定差异的原因。这些信息用于描述报告中的潜在解剖误区。

结论

在报告有症状多发性骨髓瘤的基线全身 MRI 中,观察者间具有极好的一致性。观察者间的一致性在骨骼区域之间存在差异,突出了特定的困难区域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/fe9745e06837/40644_2020_328_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/8414d218490b/40644_2020_328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/b13fc3fbc5d0/40644_2020_328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/cd8bc83bfebf/40644_2020_328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/fe9745e06837/40644_2020_328_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/8414d218490b/40644_2020_328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/b13fc3fbc5d0/40644_2020_328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/cd8bc83bfebf/40644_2020_328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c495/7362571/fe9745e06837/40644_2020_328_Fig4_HTML.jpg

相似文献

1
Inter-observer agreement of baseline whole body MRI in multiple myeloma.多发性骨髓瘤患者基线全身 MRI 的观察者间一致性。
Cancer Imaging. 2020 Jul 14;20(1):48. doi: 10.1186/s40644-020-00328-9.
2
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.全身磁共振成像(WB-MRI)报告采用前列腺癌转移报告和数据系统(MET-RADS-P):不同专业水平的读者之间的观察者间一致性。
Cancer Imaging. 2020 Oct 27;20(1):77. doi: 10.1186/s40644-020-00350-x.
3
Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.全身磁共振成像的观察者间一致性优于全身计算机断层扫描,可用于评估多发性骨髓瘤患者的疾病负担。
Eur Radiol. 2020 Jan;30(1):320-327. doi: 10.1007/s00330-019-06281-x. Epub 2019 Jul 2.
4
Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging.全身磁共振成像上局灶性骨髓瘤病变表观扩散系数和脂肪分数测量的可重复性和再现性。
Br J Radiol. 2021 Apr 1;94(1120):20200682. doi: 10.1259/bjr.20200682. Epub 2021 Mar 18.
5
Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).在 3T 全身扩散加权 MRI(WB-DW-MRI)中,复发性多发性骨髓瘤的局灶性和弥漫性病变的平均表观扩散系数测量的重复性和测试-再测试可重复性。
Br J Radiol. 2022 Sep 1;95(1138):20220418. doi: 10.1259/bjr.20220418. Epub 2022 Jul 28.
6
Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).在多发性骨髓瘤(MM)中,关于全身低剂量计算机断层扫描(WBLDCT)评估骨受累情况的观察者间一致性。
Eur Radiol. 2015 Nov;25(11):3382-9. doi: 10.1007/s00330-015-3733-0. Epub 2015 May 20.
7
Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.利用全身扩散加权成像评估骨髓瘤骨病:按区域与X线骨骼检查对比及与疾病负担实验室评估的关系
Clin Radiol. 2015 Jun;70(6):614-21. doi: 10.1016/j.crad.2015.02.013. Epub 2015 Mar 19.
8
A standardized method to measure the membranous urethral length (MUL) on MRI of the prostate with high inter- and intra-observer agreement.一种具有良好的组内和组间观察者一致性的标准化方法,用于测量前列腺 MRI 上的膜部尿道长度(MUL)。
Eur Radiol. 2023 May;33(5):3295-3302. doi: 10.1007/s00330-022-09320-2. Epub 2022 Dec 13.
9
Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI.全身 MRI 比较前列腺癌与多发性骨髓瘤的骨病变分布。
Diagn Interv Imaging. 2019 May;100(5):295-302. doi: 10.1016/j.diii.2018.12.005. Epub 2019 Jan 28.
10
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.全身 MRI 在多发性骨髓瘤治疗反应评估中的作用:临床反应与影像反应的比较。
Cancer Imaging. 2020 Jan 30;20(1):14. doi: 10.1186/s40644-020-0293-6.

引用本文的文献

1
Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myeloma.多发性骨髓瘤患者 MRI 中局灶性骨髓病变大小测量的重测信度、组内和组间信度。
Br J Radiol. 2023 Apr 1;96(1145):20220745. doi: 10.1259/bjr.20220745. Epub 2023 Apr 12.
2
Modern imaging techniques for monitoring patients with multiple myeloma.用于监测多发性骨髓瘤患者的现代成像技术。
Med Pharm Rep. 2022 Oct;95(4):377-384. doi: 10.15386/mpr-2215. Epub 2022 Oct 27.
3
Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT.

本文引用的文献

1
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.国际骨髓瘤工作组关于单克隆浆细胞疾病影像学的共识建议。
Lancet Oncol. 2019 Jun;20(6):e302-e312. doi: 10.1016/S1470-2045(19)30309-2.
2
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).骨髓瘤全身 MRI 采集、解读和报告指南:骨髓瘤反应评估和诊断系统(MY-RADS)。
Radiology. 2019 Apr;291(1):5-13. doi: 10.1148/radiol.2019181949. Epub 2019 Feb 26.
3
Whole-Body Imaging in Multiple Myeloma.
多发性骨髓瘤治疗反应和微小残留病的影像学:WB-MRI 和 PET/CT 的现状。
Skeletal Radiol. 2022 Jan;51(1):59-80. doi: 10.1007/s00256-021-03841-5. Epub 2021 Aug 7.
4
MUK OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.MUK OPTIMUM 方案:一项筛查研究,旨在识别适合新型治疗方法的多发性骨髓瘤高危患者,并结合一项 II 期研究,评估新型生物治疗联合方案在初诊高危多发性骨髓瘤和浆细胞白血病中的疗效。
BMJ Open. 2021 Mar 24;11(3):e046225. doi: 10.1136/bmjopen-2020-046225.
多发性骨髓瘤的全身成像
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):509-525. doi: 10.1016/j.mric.2018.06.006.
4
Guidelines for the use of imaging in the management of patients with myeloma.多发性骨髓瘤患者管理中影像学应用指南。
Br J Haematol. 2017 Aug;178(3):380-393. doi: 10.1111/bjh.14827. Epub 2017 Jul 5.
5
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv52-iv61. doi: 10.1093/annonc/mdx096.
6
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.己糖激酶-2低表达与多发性骨髓瘤中氟代脱氧葡萄糖正电子发射断层扫描假阴性相关。
Blood. 2017 Jul 6;130(1):30-34. doi: 10.1182/blood-2017-03-774422. Epub 2017 Apr 21.
7
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.可靠性研究中组内相关系数选择与报告指南
J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31.
8
Updated Diagnostic Criteria and Staging System for Multiple Myeloma.多发性骨髓瘤的更新诊断标准和分期系统。
Am Soc Clin Oncol Educ Book. 2016;35:e418-23. doi: 10.1200/EDBK_159009.
9
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?全身扩散加权磁共振成像:评估多发性骨髓瘤患者疾病负担的新金标准?
Leukemia. 2016 Jun;30(6):1446-8. doi: 10.1038/leu.2015.338. Epub 2015 Dec 9.
10
Whole body diffusion weighted MRI--a new view of myeloma.全身扩散加权磁共振成像——骨髓瘤的新视角。
Br J Haematol. 2015 Oct;171(1):29-37. doi: 10.1111/bjh.13509. Epub 2015 May 26.